MiR-652-3p promotes bladder cancer migration and invasion by targeting KCNN3.
CONCLUSIONS: Collectively, these results showed that miR-652-3p could promote BCa cell proliferation, migration, and invasion via directly regulating KCNN3, which may provide a novel therapeutic target for BCa treatment.
PMID: 31696467 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Bladder Cancer | Calcium | Cancer | Cancer & Oncology | Drugs & Pharmacology | Non-Small Cell Lung Cancer | Potassium | Study